232 related articles for article (PubMed ID: 21791687)
21. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and therapeutic impact of sentinel node micrometastasis in patients with invasive breast cancer.
Carcoforo P; Bergossi L; Basaglia E; Soliani G; Querzoli P; Zambrini E; Pozza E; Feggi L
Tumori; 2002; 88(3):S4-5. PubMed ID: 12365385
[TBL] [Abstract][Full Text] [Related]
23. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
24. Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery.
Ibrahim-Zada I; Grant CS; Glazebrook KN; Boughey JC
J Am Coll Surg; 2013 Jul; 217(1):7-15; discussion 15-6. PubMed ID: 23628226
[TBL] [Abstract][Full Text] [Related]
25. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy.
King TA; Ganaraj A; Fey JV; Tan LK; Hudis C; Norton L; Cody HS; Borgen PI
Cancer; 2004 Sep; 101(5):926-33. PubMed ID: 15329899
[TBL] [Abstract][Full Text] [Related]
26. Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (Pilot study).
Eldweny H; Alkhaldy K; Alsaleh N; Abdulsamad M; Abbas A; Hamad A; Mounib S; Essam T; Kukawski P; Bobin JY; Oteifa M; Amanguono H; Abulhoda F; Usmani S; Elbasmy A
J Egypt Natl Canc Inst; 2012 Mar; 24(1):23-30. PubMed ID: 23587229
[TBL] [Abstract][Full Text] [Related]
27. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.
Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ
Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218
[TBL] [Abstract][Full Text] [Related]
29. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
30. Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer.
Dong LF; Xu SY; Long JP; Wan F; Chen YD
J Int Med Res; 2018 Feb; 46(2):828-835. PubMed ID: 29441833
[TBL] [Abstract][Full Text] [Related]
31. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
[TBL] [Abstract][Full Text] [Related]
32. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
[TBL] [Abstract][Full Text] [Related]
33. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy.
Dupont EL; Kuhn MA; McCann C; Salud C; Spanton JL; Cox CE
Am J Surg; 2000 Oct; 180(4):274-7. PubMed ID: 11113434
[TBL] [Abstract][Full Text] [Related]
34. Lymph node metastasis in patients with frozen section analyses that are negative for tumors.
Lee SK; Lee KW; Kim S; Choi MY; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Lee JE; Yang JH; Nam SJ
Oncology; 2012; 83(1):31-7. PubMed ID: 22722529
[TBL] [Abstract][Full Text] [Related]
35. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
[TBL] [Abstract][Full Text] [Related]
36. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
Pargaonkar AS; Beissner RS; Snyder S; Speights VO
Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact?
Moore KH; Thaler HT; Tan LK; Borgen PI; Cody HS
Cancer; 2004 Mar; 100(5):929-34. PubMed ID: 14983487
[TBL] [Abstract][Full Text] [Related]
39. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
40. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up.
Tan LK; Giri D; Hummer AJ; Panageas KS; Brogi E; Norton L; Hudis C; Borgen PI; Cody HS
J Clin Oncol; 2008 Apr; 26(11):1803-9. PubMed ID: 18332473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
